Spots Global Cancer Trial Database for Spleen-Preserving No. 10 Lymph Node Dissection in Gastric Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Spleen-Preserving No. 10 Lymph Node Dissection in Gastric Cancer

Official Title: Study on Laparoscopic No. 10 Lymph Node Dissection With Preservation of Spleen for Advanced Middle or Upper Third Gastric Cancer

Study ID: NCT04050787

Conditions

Overall Survival

Interventions

D2 Lymphadenectomy including No. 10

D2 lymphadenectomy excluding No. 10

Study Description

Brief Summary: This study is to conduct a randomized controlled trial of two kinds of radical gastrectomy for patients with proximal gastric cancer. One is laparoscopic D2 radical total gastrectomy combined with spleen-preserving No.10 lymph node dissection , another one is laparoscopic D2 radical total gastrectomy without clearing the No. 10 lymph nodes of the spleen. We explore the effect of the two procedures on the survival of patients, as well as the surgical complications associated with the two procedures, the number of lymph node dissection, the operation time and the amount of intraoperative blood loss. Furthermore, we also want to discuss the application value of laparoscopic lymph node dissection for spleen preservation in radical gastrectomy for proximal gastric cancer.

Detailed Description: